Interplay between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: Epidemiology, pathophysiologic mechanisms, and treatment considerations-Reference-Cited by-同舟云学术

Interplay between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: Epidemiology, pathophysiologic mechanisms, and treatment considerations

Published:2022-10-21 Issue:39 Volume:28 Page:5691-5706
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:
Short-container-title:World J Gastroenterol

Author:

Theofilis Panagiotis,Vordoni Aikaterini,Kalaitzidis Rigas G

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference144 articles.

1. Obesity: global epidemiology and pathogenesis

2. Trends in Prevalence of Diabetes and Control of Risk Factors in Diabetes Among US Adults, 1999-2018

3. 2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis

4. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis

5. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epicardial and liver fat implications in albuminuria: a retrospective study;Cardiovascular Diabetology;2024-08-22

2. Interplay between metabolic dysfunction-associated fatty liver disease and renal function: An intriguing pediatric perspective;World Journal of Gastroenterology;2024-04-21

3. Association of NAFLD/NASH, and MAFLD/MASLD with chronic kidney disease: an updated narrative review;Metabolism and Target Organ Damage;2024-04-07

4. Steatotic liver disease, MASLD and risk of chronic kidney disease;Diabetes & Metabolism;2024-01

5. Cardio‐renal‐metabolic disease in primary care setting;Diabetes/Metabolism Research and Reviews;2023-12-19